Summary
The pharmaceutical market is probably one of the most highly regulated fields in the world. In combination with its unusual dynamic – supply, demand, plus a panoply of public and private stakeholders – this has given rise to market access as a new commercial discipline: Market access is about understanding which stakeholders play which roles and how to interact with them in order to get pharmaceuticals on the Danish market.
In this course, you will learn how pharmaceuticals gain access to the Danish market. You will be introduced to important stakeholders in the Danish healthcare system such as the Danish Medicines Council, Amgros, the Regions, the municipalities, general practitioners, and many others. You will be brought up to speed in terms of the structure of the healthcare system and the reimbursement system as a whole. Finally, you will practice what you learned by creating a market access strategy for a pharmaceutical product for the primary sector.
Keywords
- The Danish healthcare system
- Public and private stakeholders
- Market access in Denmark
- Market access strategy
Hi! Do you need help choosing the right course?
We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com
Course leader(s) & Lecturers
- Morten HedegaardCourse leaderNordic HEOR & HTA Manager
Bristol-Myers Squibb - Signe ThyboCourse leaderNordic HEOR & HTA Manager
Bristol-Myers Squibb
IS THIS COURSE FOR YOU?
Are you involved in local market access strategy, e.g. as a health economist, tender or reimbursement specialist? Or in other market access or regulatory areas focused on the current and upcoming market situation in Denmark? In that case, join this course. Experienced market access professionals will gain updated knowledge on a dynamic market. If you're new to market access or pharma consultancy, the course provides a quick and broad introduction to the area.
What you will learn
- How pharmaceuticals gain access to the Danish market
- How pharmaceuticals get reimbursed in Denmark
- The role of the most important stakeholders in the Danish healthcare system
- How you communicate about challenges or issues in the Danish market to your colleagues in Denmark and abroad
What your company will get
- An employee who understands Danish market access
- An employee who knows the most important stakeholders in the Danish healthcare system
- An employee who knows how to collaborate best with Danish healthcare stakeholders
- An employee who can explain challenges or issues with the Danish market to internal stakeholders in Denmark and abroad
Course calendar
DAY 1
- Framework conditions: The Danish Healthcare System and the specialty of the Pharmaceutical Industry
- The current role of the Danish Medicines council as well as in the new healthcare system
- The municipalities, the Danish healthcare system and the announced structural reform
- A new direction for the unified healthcare system and new trends
- If the Medicines Council says yes – What part does Amgros play regarding access to hospitals? (negotiations vs. offer)
- Recap of the day
DAY 2
- The role and function of the general practitioners as gatekeepers in the healthcare system
- If the Medicines Council says no – Cross-regional forum, Task Force and RLK
- The Reimbursement system
- Preparation of a market access strategy for a product to the primary sector
- Rounding off the day
Registration
Registration deadline20. Feb 2022
Lersø Parkallé 101
2100 København Ø
DAY 1
- Framework conditions: The Danish Healthcare System and the specialty of the Pharmaceutical Industry
- The current role of the Danish Medicines council as well as in the new healthcare system
- The municipalities, the Danish healthcare system and the announced structural reform
- A new direction for the unified healthcare system and new trends
- If the Medicines Council says yes – What part does Amgros play regarding access to hospitals? (negotiations vs. offer)
- Recap of the day
DAY 2
- The role and function of the general practitioners as gatekeepers in the healthcare system
- If the Medicines Council says no – Cross-regional forum, Task Force and RLK
- The Reimbursement system
- Preparation of a market access strategy for a product to the primary sector
- Rounding off the day
Registration
Registration deadline4. Sep 2022
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.
Please familiarize yourself with the mandatory readings before starting the course. The mandatory readings are also part of the examination syllabus.
Examination
The exam is usually held 4-6 weeks after the course. You can take the exam in your own country.
Please let us know if this is relevant for you as we can conduct exams at embassies, universities and so on worldwide.
Once you have attended all four market access courses, you can take the exam. The exam is held twice a year, once in the spring and once in the fall.
The exam is a written take-home assignment in which you must demonstrate that you are able to plan a market access strategy that includes the relevant stakeholders and decision makers. You have three weeks to finish your assignment
This course is a part of this programme
Our Market Access Programme provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses
Read morePharma Consultant Programme
Design a medical training programme that fits your professional interests. Relevant if you work with or advice on drugs, maybe as a professional in sales and marketing, market access or public affairs in the pharma industry
Read moreCourse leader(s)
Bristol-Myers Squibb
Bristol-Myers Squibb
You may also be interested in these courses
WANT TO KNOW MORE or need help?
Contact Client Manager Birger Flinthagen at +45 39 15 09 06
Send me a message